ESSA Pharma schedules Aug 5 court hearing for cash distribution in XenoTherapeutics deal; provides PFIC tax guidance

ESSA Pharma Inc.

Court hearing for Distribution Order set for August 5, 2025 at 9:45 a.m. PT in Vancouver.
Company plans to reduce capital and distribute cash to shareholders as part of winding-up prior to XenoTherapeutics closing.
Company believes it was a PFIC for FY2024 and expects PFIC status for current year; provides detailed U.S. tax guidance for Distribution.
U.S. Holders receiving cash may recognize capital gain/loss; PFIC rules could apply absent a QEF or mark-to-market election.
Shareholders urged to review proxy statement for full tax and deal details.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.